While the number of homebirths in the United States has grown over the last decade, researchers at New York-Presbyterian/Weill Cornell Medical Center have found that babies born at home are roughly 10 times as likely to be stillborn and almost four times as likely to have neonatal seizures or serious neurologic dysfunction when compared to babies born in hospitals.

There have been a multitude of firsts, celebrated successes, groundbreaking research findings, and more than 4,000 lives saved — and that was just in the first 50 years. This week NewYork-Presbyterian/Weill Cornell Medical Center and The Rogosin Institute celebrate the 50th anniversary of their world-renowned transplant program.

Dr. John Leonard, an internationally-recognized hematology and oncology expert specializing in the treatment of lymphomas at Weill Cornell Medical College, has been named chair of the Lymphoma Committee for the prestigious National Cancer Institute-sponsored group, the Alliance for Clinical Trials in Oncology. Dr. Leonard is the associate dean for clinical research at Weill Cornell and director of the Joint Clinical Trials Office at Weill Cornell and NewYork-Presbyterian Hospital/Weill Cornell Medical Center

Colon cancer, the number two cancer killer in the United States, is often preventable and highly curable.

NewYork-Presbyterian Hospital celebrated the dedication of the W. P. Carey Emergency Unit at a ceremony held on Thursday, May 2, 2013. Made possible by a $5 million gift from the W. P. Carey Foundation, the facility is a critical component of the hospital's emergency services.

Dr. Augustine M. K. Choi has been appointed chairman of the Department of Medicine at Weill Cornell Medical College and physician-in-chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, effective Aug. 1, 2013. Dr. Choi currently is the Parker B. Francis Professor of Medicine at Harvard Medical School and chief of pulmonary and critical care medicine at Brigham and Women's Hospital in Boston.

A summary of information for cancer patients from New York-Presbyterian. As a leader in cancer care, NewYork-Presbyterian treats over 7,000 adult and pediatric patients newly diagnosed with cancer each year. As a leader in cancer research, our physician-scientists and researchers lead more than 500 clinical trials involving thousands of patients. And, the results of this research frequently moves from "bench to bedside" to become tomorrow's standard therapies.

Dr. Lewis Cantley, a leading cancer researcher credited with discovering a family of enzymes fundamental to understanding cancer, was named a winner of the inaugural Breakthrough Prize in Life Sciences, the world's richest academic prize for medicine and biology. The prize, which carries a $3 million cash award, recognizes excellence in research aimed at curing intractable diseases and human life.